Cardiodynamic studies of antihypertensive agents have been carried out using the totally noninvasive method of thoracic impedance (Hill & Thompson 1975) . The observations on atenolol presented in this paper cover the acute changes with intravenous therapy, the early changes after a single oral dose and long-term changes with oral therapy. Fig 1 shows the results in two patients after receiving intravenous atenolol, in the one case 5 mg and in the other 25 mg. Blood pressure, pulse, stroke volume, cardiac output and calculated peripheral resistance at rest, before and 20 minutes after the intravenous dose are shown. There was an increase in cardiac output and in stroke volume and a fall in calculated peripheral resistance (lower with 5 mg) and a reduction in pulse rate. In one patient there was no change and in the other, on the lower dose, there was a small fall in blood pressure.
Eight patients were given a single oral dose of 100 mg atenolol. In There was now a just significant fall in diastolic blood pressure and rise in stroke volume and a significant fall in pulse rate. One to 41 months after starting oral atenolol in a dose ranging from 75-200 mg daily usually in two doses, there was a significant fall in the lying blood pressure, a significant but no greater fall of the standing systolic blood pressure and significant falls of the same degree in the lying and standing diastolic blood pressures (Fig 4) . As with the early results the pulse rate was also significantly lower than the control observations. Fig 5 shows the observations in a patient 11 weeks and 18 months after starting oral treatment with 100 mg daily. The blood pressure remainied the same for a year on this treatment after the observations shown at 18 months. This patient was a 40-year-old man who received a kidney transplant in April, 1974, with a blood pressure at that time with diastolic values of 90-100 mmHg. Over the next seven months the blood pressure gradually rose and at the time atenolol was started both lying and standing diastolic blood pressures were between 120 and 140 mmHg. This is the same patient illustrated in Fig 1 receiving an intravenous injection of 25 mg atenolol.
In a group of 6 patients on oral atenolol, who had good but not adequate control of their blood pressure, a vasodilator, either hydrallazine or minoxidil was added, resulting in an adequate control of both systolic and diastolic blood pressure. However, the better blood pressure control was accompanied by an increase of the pulse rate to the control observation level (Fig 6) .
Renal function as measured by plasma creatinine is shown in Fig 6 (Joekes et al. 1974) with those on atenolol the main difference has been a reduced stroke volume early in the treatment with 
